Levosimendan in Cardiogenic Shock: A Review of Mechanisms, Clinical Evidence, and Therapeutic Use
Stefano Salvini, Valeria Trivelloni, Ilenia Monaco, Fatima Samet Bouhaik, Insaf Chouarfia, Iheb Guefrachi, Yassine Bencharef, Mounia Sedrati, Charaf Mouhand, Dario Bottigliero · 2026
Read Levosimendan in Cardiogenic Shock: A Review of Mechanisms, Clinical Evidence, and Therapeutic Use by Stefano Salvini, Valeria Trivelloni, Ilenia Monaco, Fatima Samet Bouhaik, Insaf Chouarfia, Iheb Guefrachi, Yassine Bencharef, Mounia Sedrati, Charaf Mouhand, Dario Bottigliero (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13227365.txt.
Description
Stefano Salvini and co-authors review a 2026 evidence base for levosimendan in cardiogenic shock, the state where a failing heart cannot supply the body. The drug strengthens contraction without raising the heart's calcium load or oxygen appetite, and it opens blood vessels through potassium channels. That profile differs sharply from adrenaline-like drugs and has renewed interest in its use.
Blood-flow improvements appear consistently across studies, but large randomised trials have not delivered a consistent survival benefit. Timing, patient selection, and background therapy probably explain the gap. Groups more likely to gain include patients unresponsive to standard drugs, those on long-term beta blockers, and some surgical or machine-supported cases. Ongoing trials in related settings may sharpen the picture.
Catalog record
| CREATOR | Stefano Salvini, Valeria Trivelloni, Ilenia Monaco, Fatima Samet Bouhaik, Insaf Chouarfia, Iheb Guefrachi, Yassine Bencharef, Mounia Sedrati, Charaf Mouhand, Dario Bottigliero |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |